Application value of Da Vinci robot-assisted Roux-en-Y gastric bypass in treating obesity

doi:10.3877/cma.j.issn.2095-9605.2017.01.004

Abstract

Abstract:

Objective

To investigate the clinical application value of robot-assisted Roux-en-Y gastric bypass (RRYGB) in treating obesity.

Methods

Clinical data of 9 obese patients undergoing bariatric surgery in Xiehe Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from July 2012 to November 2016 were retrospectively studied. The informed consents of all patients were obtained and the local ethical committee approval had been received. According to whether RRYGB was carried out or not, these patients were divided into the RRYGB group and the laparoscopic Roux-en-Y gastric bypass (LRYGB) group. Three patients were included into the RRYGB group, of whom 1 was male and 2 were females with an average age of (37±7) years old. Six patients were included into the LRYGB group, of whom 3 were males and 3 were females with an average age of (31±7) years old. Operation time, intraoperative blood loss, postoperative ventilation time, postoperative hospital stay; and body weight, body mass index (BMI), fasting plasma glucose (FPG), low density lipoprotein (LDL), high density lipoprotein (HDL), triglyceride (TG) and total cholesterol (TC) before and 1 month after operation were compared between the two groups. Comparisons of these data between the two groups were conducted using t test or χ² test.

Results

All the patients received bariatric surgery successfully. Intraoperative blood loss of the RRYGB group was (46±7) ml, which was significantly lower than (82±6) ml of the LRYGB group (t= –8.03, P<0.05). One month after operation, BMI of the RRYGB and LRYGB groups were (34±5) and (35±4) kg/m² respectively, which were significantly lower than (39±7) and (40±5) kg/m² before operation (t=5.33, 7.33, P<0.05); and there is no statistical difference in BMI reduction between the two groups.

Conclusions

RRYGB is a therapeutic method with a good short-term effect on obesity, but its safety and effectiveness remain to be further investigated because the number of patients was too small and the fellow-up time was not long enough in this research.

Key words: Da Vinci robot-assisted Roux-en-Y gastric bypass, Laparoscopic Roux-en-Y gastric bypass, Obesity

Zefeng Xia, Qingbo Wang, Xiaoming Shuai, Jinbo Gao, Ming Cai, Geng Wang, Chaojie Hu, Anshu Li, Jinpeng Du, Ning Zhao, Guobin Wang, Kaixiong Tao. Application value of Da Vinci robot-assisted Roux-en-Y gastric bypass in treating obesity[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2017, 03(01): 19-24.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2017.01.004

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2017/V03/I01/19

Figures/Tables 7

References 15

[1]	王存川，沈莹莹，杨景哥. 腹腔镜Roux-en-Y胃旁路手术治疗肥胖症[J]. 腹腔镜外科杂志, 2011, 16(4):243-246.
[2]	中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖和2型糖尿病外科治疗指南（2014）[J]. 中国实用外科学杂志, 2014, 34(11):1005-1010.
[3]	Mason EE, Ito C. Gastric bypass in obesity[J]. Surg Clin North Am, 1967, 47(6):1345-1351.
[4]	Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012, 366(17):1577-1585.
[5]	Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials[J]. Can J Surg, 2013, 56(6):E158-E164.
[6]	Helmiö M, Victorzon M, Ovaska J, et al. SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleevegastrectomy and gastric bypass in the treatment of morbid obesity:preliminary results[J]. Surg Endosc, 2012, 26(9):2521-2526.
[7]	Ramón JM, Salvans S, Crous X, et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial[J]. J Gastrointest Surg, 2012, 16(6):1116-1122.
[8]	Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases[J]. Obes Surg, 1994, 4(4):353-357.
[9]	Kehagias I, Karamanakos SN, Argentou M, et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI<50 kg/m²[J]. Obes Surg, 2011, 21(11):1650-1656.
[10]	刘金鸽，张立超，马利锋, 等. 腹腔镜袖状胃切除术在治疗病态肥胖症中的应用价值[J]. 中华肥胖与代谢病电子杂志, 2016, 2(1):17-21.
[11]	Markar SR, Karthikesalingam AP, Venkat-Ramen V, et al. Robotic vs laparoscopic Roux-en-Y gastric bypass in morbidly obese patients: systematic review and pooled analysis[J]. Int J Med Robot, 2011, 7(4):393-400.
[12]	Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: Outcomes, quality of life, and costs[J]. Ann Surg, 2009, 250(4):631-641.
[13]	Vilallonga R, Fort JM, Gonzalez O, et al. The initial learning curve for robot-assisted sleeve gastrectomy: a surgeon’s experience while introducing the robotic technology in a bariatric surgery department[J]. Minim Invasive Surg, 2012(2012):347131.
[14]	Rezvani M, Sucandy I, Antanavicius G. Totally robotic stapleless vertical sleeve gastrectomy[J]. Surg Obes Relat Dis, 2013, 9(5):e79-e81.
[15]	Buchs NC, Pugin F, Bucher P, et al. Learning curve for robot-assisted Roux-en-Y gastric bypass[J]. Surg Endosc, 2012, 26(4):1116-1121.

组别	例数	性别（例）		年龄（岁）	身高（m）	体质量（kg）	BMI（kg/m²）
组别	例数	男	女	年龄（岁）	身高（m）	体质量（kg）	BMI（kg/m²）
RRYGB组	3	1	2	37±7	1.67±0.09	110±32	39±7
LRYGB组	6	3	3	31±7	1.72±0.06	118±16	40±5
统计值	?	χ²=1.00		t=1.17	t= –0.88	t= –0.41	t= –0.20
P值	?	>0.05		>0.05	>0.05	>0.05	>0.05
组别	例数	FPG（mmol/L）	TG（mmol/L）	TC（mmol/L）	LDL（mmol/L）	HDL（mmol/L）
RRYGB组	3	4.8±1.3	1.9±0.6	4.8±1.4	3.4±1.3	1.24±0.13
LRYGB组	6	5.6±0.6	1.3±0.5	4.7±0.6	3.0±0.7	1.56±0.87
统计值	?	t= –1.04	t=1.34	t=0.09	t=0.45	t= –0.87
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	性别（例）		年龄（岁）	身高（m）	体质量（kg）	BMI（kg/m²）
组别	例数	男	女	年龄（岁）	身高（m）	体质量（kg）	BMI（kg/m²）
RRYGB组	3	1	2	37±7	1.67±0.09	110±32	39±7
LRYGB组	6	3	3	31±7	1.72±0.06	118±16	40±5
统计值	?	χ²=1.00		t=1.17	t= –0.88	t= –0.41	t= –0.20
P值	?	>0.05		>0.05	>0.05	>0.05	>0.05
组别	例数	FPG（mmol/L）	TG（mmol/L）	TC（mmol/L）	LDL（mmol/L）	HDL（mmol/L）
RRYGB组	3	4.8±1.3	1.9±0.6	4.8±1.4	3.4±1.3	1.24±0.13
LRYGB组	6	5.6±0.6	1.3±0.5	4.7±0.6	3.0±0.7	1.56±0.87
统计值	?	t= –1.04	t=1.34	t=0.09	t=0.45	t= –0.87
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	术中出血量（ml）	手术时间（min）	术后排气时间（d）	术后住院时间（d）	住院总费用（万元）
RRYGB组	3	46±7	336±81	2.7±0.6	13±7	7.3±0.6
LRYGB组	6	82±6	258±46	3.3±0.8	9±3	6.4±0.8
t值	?	–8.03	1.54	–1.40	1.46	2.10
P值	?	<0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	术中出血量（ml）	手术时间（min）	术后排气时间（d）	术后住院时间（d）	住院总费用（万元）
RRYGB组	3	46±7	336±81	2.7±0.6	13±7	7.3±0.6
LRYGB组	6	82±6	258±46	3.3±0.8	9±3	6.4±0.8
t值	?	–8.03	1.54	–1.40	1.46	2.10
P值	?	<0.05	>0.05	>0.05	>0.05	>0.05

组别	例数	BMI（kg/m²）	BMI减少量（kg/m²）	FPG（mmol/L）	TG（mmol/L）	TC（mmol/L）	LDL（mmol/L）	HDL（mmol/L）
RRYGB组	3	34±5	5.7±1.9	5.4±1.4	1.6±0.7	4.6±0.6	2.71±0.11	1.15±0.19
LRYGB组	6	35±4	5.3±1.8	4.7±0.7	1.5±0.5	4.4±0.7	2.57±0.38	1.21±0.27
t值	?	–0.46	0.35	–1.89	1.80	–0.27	0.30	–0.88
P值	?	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

Please choose a citation manager

Content to export